You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dacomitinib

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among

Recruiting
  • Lung Cancer
  • Dacomitinib
  • Kuala Lumpur, Malaysia
  • +2 more
Nov 21, 2022

NSCLC Stage IIIB, NSCLC Stage IIIC, NSCLC Stage IV Trial in Worldwide (Dacomitinib)

Active, not recruiting
  • NSCLC Stage IIIB
  • +4 more
  • Dacomitinib
  • Hong Kong, Hong Kong
  • +8 more
Jan 10, 2023

NSCLC (NSCLC) Trial (Dacomitinib+Anlotinib, Dacomitinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • (no location specified)
Feb 28, 2022

Metastatic NSCLC Trial in United States (Dacomitinib, Osimertinib)

Active, not recruiting
  • Metastatic Non-small Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Dec 28, 2021

Metastatic Non Small Cell Lung Cancer Trial in India (Dacomitinib)

Active, not recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Dacomitinib
  • New Delhi, Delhi, India
  • +13 more
Jan 20, 2022

Cancer Medicines in Metastatic Non-small Cell Lung Cancer in

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Oslo, Norway
    Pfizer Norway
Apr 17, 2023

EGFR Gene Mutation, Lung Cancer, Lung Cancer Metastatic Trial in United States (Dacomitinib, Osimertinib)

Recruiting
  • EGFR Gene Mutation
  • +2 more
  • Basking Ridge, New Jersey
  • +7 more
Aug 27, 2021

Penile Tumors, Carcinoma, Squamous Cell Trial in Milan (Dacomitinib)

Completed
  • Penile Neoplasms
  • Carcinoma, Squamous Cell
  • Dacomitinib
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
May 12, 2021

Followed by 3rd Generation EGFR-TKI in EGFR Mutation Positive

Recruiting
  • EGFR Activating Mutation
  • +3 more
  • Dacomitinib
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 23, 2021

Non Small Cell Lung Cancer, Brain Metastases Trial in Seoul (Dacomitinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Brain Metastases
  • Dacomitinib
  • Seoul, Korea, Republic of
    Jong-Mu Sun
Jan 1, 2021

Severe Hepatic Impairment Trial in Miami, Orlando (Dacomitinib)

Completed
Has Results
  • Severe Hepatic Impairment
  • Dacomitinib
  • Miami, Florida
  • +2 more
Oct 13, 2020

NSCLC Trial in Japan (Dacomitinib)

Completed
Has Results
  • NSCLC
  • Dacomitinib
  • Kanazawa City, Ishikawa, Japan
  • +5 more
Jul 1, 2020

Dacomitinib for EGFR Mutated NSCLC (NSCLC) With Brain Metastases Trial (Dacomitinib)

Not yet recruiting
  • Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases
  • Dacomitinib
  • (no location specified)
Apr 7, 2020

Bevacizumab Plus EGFR-TKIs in Chinese EGFR-mutant

Recruiting
  • NSCLC
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Oct 17, 2020

NSCLC Trial in Italy (Osimertinib, Dacomitinib)

Recruiting
  • NSCLC
  • Arezzo, AR, Italy
  • +19 more
May 4, 2021

Tumor Trial in Worldwide (PF-05212384 (gedatolisib), Docetaxel, Cisplatin)

Completed
Has Results
  • Neoplasm
  • PF-05212384 (gedatolisib)
  • +3 more
  • Birmingham, Alabama
  • +28 more
Sep 9, 2021

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Colorectal Cancer Trial in Amsterdam, Rotterdam, Utrecht (Dacomitinib, PD-0325901, Docetaxel)

Unknown status
  • Colorectal Cancer
  • Dacomitinib
  • +2 more
  • Amsterdam, Netherlands
  • +2 more
Aug 24, 2018

Non Small Cell Lung Cancer (NSCLC) Trial in Korea, Republic of, United States (Dacomitinib, Doxycycline, Probiotic)

Completed
Has Results
  • Non Small Cell Lung Cancer (NSCLC)
  • Dacomitinib
  • +3 more
  • Duarte, California
  • +80 more
Dec 20, 2018

NSCLC Trial in Korea, Republic of, United States (Dacomitinib)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Dacomitinib
  • Beverly Hills, California
  • +13 more
Jul 17, 2017

Brain Cancer Trial in La Jolla (Dacomitinib)

Terminated
Has Results
  • Brain Cancer
  • Dacomitinib
  • La Jolla, California
    UCSD Moores Cancer Center
Aug 8, 2016

Skin Squamous Cell Cancer Trial in Milan (Dacomitinib)

Unknown status
  • Skin Squamous Cell Cancer
  • Dacomitinib
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Jul 1, 2016

Squamous Cell Carcinoma of the Head and Neck Trial in Toronto (dacomitinib, Radiotherapy, Cisplatin)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • dacomitinib
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jun 9, 2016

Healthy Trial in Beijing (Dacomitinib)

Completed
  • Healthy
  • Dacomitinib
  • Beijing, China
    Peking Union Medical College Hospital
Oct 2, 2014

Healthy, Otherwise Healthy Volunteers With Mild or Moderate Hepatic Dysfunction Trial in Anaheim, South Miami (dacomitinib)

Completed
  • Healthy
  • Otherwise Healthy Volunteers With Mild or Moderate Hepatic Dysfunction
  • dacomitinib
  • Anaheim, California
  • +1 more
Dec 16, 2013